NCT01659827已完成不适用
A Prospective, Randomized, Blinded, Comparative Study of Amniotic Membrane Injectable in the Treatment of Recalcitrant Plantar Fasciitis
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 45
- 试验地点
- 3
- 主要终点
- Change from Baseline in American Orthopaedic Foot and Ankle Society (AOFAS) Hind Foot Score at 8 Weeks
研究概览
简要总结
The purpose of this study is to determine whether the AmnioFix Injectable human amniotic membrane is effective in the treatment of recalcitrant plantar fasciitis.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •At least 18 years old.
- •Both male and female patients will be selected.
- •Plantar fasciitis has been treated with conservative usual care for at least 8 weeks, including at least three of the following modalities
- •Corticosteroid injection
- •Stretching exercises
- •Females of childbearing potential must be willing to use acceptable methods of contraception (birth control pills, barriers, or abstinence).
- •Patient understands and is willing to participate in the clinical study and can comply with weekly visits and the follow-up regimen.
- •Patient has read and signed the IRB/IEC approved Informed Consent Form before screening procedures are undertaken.
排除标准
- •Prior surgery at the site
- •Site that exhibits clinical signs and symptoms of infection
- •History of chronic plantar fasciitis of more than twelve months
- •Evidence of significant neurological disease of the feet
- •Non Ambulatory Patients
- •The presence of comorbidities that can be confused with or can exacerbate the condition including:
- •Calcaneal stress fracture
- •Nerve entrapment syndrome (baxter nerve syndrome or tarsal tunnel)
- •Plantar fascial rupture
- •Systemic disorders associated with enthesiopathy such as Gout, Reiters syndrome, rheumatoid arthritis, etc.
- •Achilles tendonitis
- •Fat pad atrophy
- •Fibromyalgia
- •Patients with a history of more than two weeks treatment with immuno-suppressants (including systemic corticosteroids), cytotoxic chemotherapy within one month prior to initial screening, or who receive such medications during the screening period, or who are anticipated to require such medications during the course of the study.
- •Patients on any investigational drug(s) or therapeutic device(s) within 30 days preceding Screening.
- •History of radiation at the site.
- •Known history of having Acquired Immunodeficiency Syndrome (AIDS) or HIV.
- •Study foot has been previously treated with tissue engineered materials such as PRP within the last 30 days.
- •Patients who are unable to understand the aims and objectives of the trial.
- •Presence of any condition(s) which seriously compromises the subject's ability to complete this study, or has a known history of poor adherence with medical treatment.
- •Pregnant or breast feeding. No pregnancy within the past 6 months.
- •Allergy to Gentamycin Streptomycin
结局指标
主要结局
Change from Baseline in American Orthopaedic Foot and Ankle Society (AOFAS) Hind Foot Score at 8 Weeks
时间窗: 8 Weeks
次要结局
- Time to return to normal activities(Up to 8 Weeks)
- Pain scale(Weekly up to 8 Weeks)
研究者
研究点 (3)
Loading locations...
相似试验
已完成
不适用
Comparative Study of Amniotic Membrane Wound Graft In the Management of Diabetic Foot UlcersDiabetic Foot UlcerNCT01552499MiMedx Group, Inc.25
已完成
不适用
Randomized Clinical Trial Using Amniotic Membrane in Robotic Assisted Laparoscopic ProstatectomyPudendal NerveNCT01832168MiMedx Group, Inc.34
已完成
3 期
A study to evaluate the efficacy of amniotic membrane as a wound dressing in patients with large wound following trauma.CTRI/2019/08/020572INSTITUTE RESEARCH GRANT60
已完成
不适用
Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg UlcersVenous Leg UlcerNCT01552447MiMedx Group, Inc.98
终止
不适用
Human Amniotic Membrane On Venous Leg Ulcers In an Elderly PopulationVenous Leg UlcerNCT06544564BioLab Holdings30